• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜型-1-基质金属蛋白酶(MT1-MMP)表达诱导的明胶酶A的细胞表面结合与激活。

Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).

作者信息

Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson W G, Seiki M

机构信息

Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Japan.

出版信息

FEBS Lett. 1996 May 6;385(3):238-40. doi: 10.1016/0014-5793(96)00389-4.

DOI:10.1016/0014-5793(96)00389-4
PMID:8647259
Abstract

Gelatinase A is secreted as a proenzyme (progelatinase A) which is activated and bound on the surface of tumor and normal cells. We have reported that the expression of a membrane-type-1-matrix metalloproteinase (MT1-MMP) induces activation of progelatinase A. Here we demonstrate that the expression of MT1-MMP in COS-1 cells induces cell-surface binding of progelatinase A which is consequently processed to an intermediate form. Processing from the intermediate to the fully active form is dependent on the gelatinase A concentration. These results suggest that the cell-surface binding concentrates the gelatinase A intermediate form locally to allow autoproteolytic processing to the fully active form.

摘要

明胶酶A以酶原形式(前明胶酶A)分泌,该酶原在肿瘤细胞和正常细胞表面被激活并结合。我们曾报道,膜型1基质金属蛋白酶(MT1-MMP)的表达可诱导前明胶酶A的激活。在此我们证明,MT1-MMP在COS-1细胞中的表达可诱导前明胶酶A在细胞表面的结合,进而使其加工成中间形式。从中间形式加工成完全活性形式取决于明胶酶A的浓度。这些结果表明,细胞表面结合将明胶酶A中间形式局部浓缩,从而允许其自动蛋白水解加工成完全活性形式。

相似文献

1
Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).膜型-1-基质金属蛋白酶(MT1-MMP)表达诱导的明胶酶A的细胞表面结合与激活。
FEBS Lett. 1996 May 6;385(3):238-40. doi: 10.1016/0014-5793(96)00389-4.
2
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.膜型1基质金属蛋白酶的可溶性催化结构域可切割前明胶酶A的前肽并启动自身蛋白水解激活。受金属蛋白酶组织抑制因子-2(TIMP-2)和金属蛋白酶组织抑制因子-3(TIMP-3)调控。
J Biol Chem. 1996 Jul 19;271(29):17119-23. doi: 10.1074/jbc.271.29.17119.
3
Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.膜型-1基质金属蛋白酶的蛋白水解加工与细胞表面明胶酶A的激活相关。
Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):345-53. doi: 10.1042/bj3340345.
4
Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.大鼠皮肤伤口愈合过程中基质金属蛋白酶的表达:膜型-1基质金属蛋白酶是前明胶酶A的基质激活剂的证据。
J Cell Biol. 1997 Apr 7;137(1):67-77. doi: 10.1083/jcb.137.1.67.
5
Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain.
J Biol Chem. 1996 Nov 22;271(47):30174-80. doi: 10.1074/jbc.271.47.30174.
6
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.TIMP2膜型1金属蛋白酶“受体”调节前明胶酶A的浓度和有效激活。一项动力学研究。
J Biol Chem. 1998 Jan 9;273(2):871-80. doi: 10.1074/jbc.273.2.871.
7
Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.细胞侵袭中的膜型基质金属蛋白酶(MT - MMPs)
Thromb Haemost. 1997 Jul;78(1):497-500.
8
Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.人骨关节炎软骨中膜型1基质金属蛋白酶的表达及前胶原酶A的激活
Am J Pathol. 1997 Jul;151(1):245-56.
9
Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.中性粒细胞蛋白酶对肿瘤细胞基质金属蛋白酶-2的激活需要膜型1基质金属蛋白酶的表达。
Surgery. 1998 Aug;124(2):232-8.
10
Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.人星形细胞瘤中膜型1、2和3基质金属蛋白酶的表达及组织定位
Am J Pathol. 1999 Feb;154(2):417-28. doi: 10.1016/S0002-9440(10)65288-1.

引用本文的文献

1
Potential target within the tumor microenvironment - MT1-MMP.肿瘤微环境中的潜在靶点——基质金属蛋白酶1(MT1-MMP)
Front Immunol. 2025 Mar 24;16:1517519. doi: 10.3389/fimmu.2025.1517519. eCollection 2025.
2
Metalloproteases and their inhibitors in the postpartum endometrial remodeling in dairy cows: their relationship with days to conception after parturition.奶牛产后子宫内膜重塑中的金属蛋白酶及其抑制剂:它们与产后受孕天数的关系。
Vet Res Commun. 2024 Dec 23;49(1):53. doi: 10.1007/s11259-024-10622-7.
3
Melanoma Mediated Disruption of Brain Endothelial Barrier Integrity Is Not Prevented by the Inhibition of Matrix Metalloproteinases and Proteases.
黑色素瘤导致的血脑屏障完整性破坏不能通过基质金属蛋白酶和蛋白酶抑制剂来预防。
Biosensors (Basel). 2022 Aug 19;12(8):660. doi: 10.3390/bios12080660.
4
Extracellular Matrix Remodeling by Fibroblast-MMP14 Regulates Melanoma Growth.成纤维细胞-MMP14 对细胞外基质的重塑调控黑色素瘤的生长。
Int J Mol Sci. 2021 Nov 12;22(22):12276. doi: 10.3390/ijms222212276.
5
Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP.APP代谢和阿尔茨海默病发病机制中新兴的替代蛋白酶:聚焦MT1-MMP和MT5-MMP
Front Aging Neurosci. 2019 Sep 24;11:244. doi: 10.3389/fnagi.2019.00244. eCollection 2019.
6
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.基质金属蛋白酶、血管重塑与血管疾病
Adv Pharmacol. 2018;81:241-330. doi: 10.1016/bs.apha.2017.08.002. Epub 2017 Sep 19.
7
Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.妊娠期高血压期间子宫胎盘和子宫动脉基质金属蛋白酶-9的同源二聚化减少及与金属蛋白酶组织抑制因子-1(TIMP-1)的复合增加。
Biochem Pharmacol. 2017 Aug 15;138:81-95. doi: 10.1016/j.bcp.2017.05.005. Epub 2017 May 12.
8
Biochemical and Biological Attributes of Matrix Metalloproteinases.基质金属蛋白酶的生化及生物学特性
Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22.
9
Incorporation of β-actin loading control into zymography.将β-肌动蛋白上样对照纳入酶谱分析。
J Biol Methods. 2016 Nov 1;3(4). doi: 10.14440/jbm.2016.157.
10
Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.基质金属蛋白酶作为癌症中可控递送的靶点:上调与表达分析
J Control Release. 2017 Aug 10;259:62-75. doi: 10.1016/j.jconrel.2017.01.034. Epub 2017 Jan 31.